References
- Ait-Daoud N., Johnson B. Combining ondansetron and naltrexone reduces craving among biologically predisposed alcoholics: prelimniary clinical evidence. Psychopharmacology 2001; 154(1)23–27, [PUBMED], [INFOTRIEVE]
- Anton R. F. Neurobehavioural basis for the pharmacotherapy of alcoholism: current and future directions. Alcohol & Alcoholism 1996; 31: 43–53, Suppl. 1[INFOTRIEVE]
- Anton R. F., Moak D. H. Naltrexone and cognitive behavioral therapy for treatment of outpatient alcoholics: result a placebo-controlled trial. American Journal of Psychiatry 1999; 156(11)1758–1764, [PUBMED], [INFOTRIEVE]
- Ashley O., Marsden M. Effectiveness of substance abuse treatment programming for women: a review. Journal of Drug & Alcohol Abuse 2003; 29(1)19–53, [INFOTRIEVE], [CROSSREF]
- Beach C., Mays D. Inhibition of elimination of caffeiene by disulfiram in normal subjects and recovering alcoholics. Clinical Pharmacology & Therapeutics 1986; 39: 265–270, [INFOTRIEVE]
- Berlin R. Disulfiram hepatoxicity: a consideration of its mechanism and clinical spectrum. Archives of General Psychiatry 1989; 24: 241–246
- Bigelow G., Stricker D. Maintaining disulfiram ingestion among outpatient alcoholic: a security-deposit contingency contracting procedure. Behaviour Research & Therapy 1976; 14: 378–381, [INFOTRIEVE], [CROSSREF]
- Boileau I., Assaad J. Alcohol promotes dopamine release in the human nucleus accumbens. Synapse 2003; 49(4)226–231, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Brady K., Myrick H. The use of divalproex in alcohol relapse prevention: a pilot study. Drug & Alcohol Dependence 2002; 67(3)323–330, [INFOTRIEVE], [CROSSREF]
- Brady K., Sonne S. Sertraline treatment of comorbid post traumatic stress disorder and alcohol dependence. Journal of Clinical Psychiatry 1995; 56: 502–505, [PUBMED], [INFOTRIEVE]
- Brienza R., Stein M. Alcohol use disorders in primary care: do gender-specific differnces exist?. Journal of General Internal Medicine 2002; 17(5)387–397, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Brown C., Kaminksy M. Delirium with Phenytoin and Disulfiram Administration. Annals of Emergency Medicine 1983; 12: 310–313, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Carroll K., Rounsaville B. Alcoholism in treatment-seeking cocaine abusers: clinical and prognostic signifigance. Journal of Studies on Alcohol 1993; 54(2)199–208, [PUBMED], [INFOTRIEVE]
- Chick J. Safety issues concerning the use of disulfiram in treating alcohol dependence. Drug Safety 1999; 20(5)427–435, [PUBMED], [INFOTRIEVE]
- Ciraulo D. A., Barnhill J. Pharmacokinetic interaction of disulfiram and antidepressants. American Journal of Psychiatry 1985; 142(11)1373–1374, [PUBMED], [INFOTRIEVE]
- Cloninger C. R., Bohman M. Inheritance of alcohol abuse. Cross-fostering analysis of adopted men. Archives of General Psychiatry 1981; 38(8)861–868, [PUBMED], [INFOTRIEVE]
- Cornelius J., Salloum I. Preliminary report: double-blind, placebo controlled study of fluoxetine in depressed alcoholics. Psychopharmacology Bulletin 1995; 31: 297–303, [PUBMED], [INFOTRIEVE]
- Cornelius J. R., Jarrett P. J. Gender effects on the clinical presentation of alcoholics at a psychiatric hospital. Comprehensive Psychiatry 1995; 36(6)435–440, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Cornelius J. R., Thase M. E. Cocaine use associated with increased suicidal behavior in depressed alcoholics. Addictive Behaviors 1998; 23(1)119–121, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Croop D. F. R. S., Faulkner E. B. The safety profile of naltrexone in the treatment of alcoholism. Results from a multicenter usage study. The Naltrexone Usage Study Group. Archives of General Psychiatry 1997; 54(12)1130–1135, [PUBMED], [INFOTRIEVE]
- Davies M. The Role of GABA receptors in Mediating the Effects of Alcohol in the Central Nervous System. Journal of Psychiatry & Neuroscience 2003; 28(4)263–274, [INFOTRIEVE]
- Davis K., Wu J. Role of glutamatergic and GABAergic systems in alcoholism. Journal of Biomedical Science 2001; 8: 7–19, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Dawson D., Grant B. Subgroup variations in US drinking patterns: results of the 1992 national longitudinal alcoholic epidemiologic study. Journal of Substance Abuse 1995; 7(3)331–344, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Dingledine R., Borges K. The glutamate receptor ion channels. Pharmacological Reviews 1999; 51(1)7–61, [PUBMED], [INFOTRIEVE]
- Drake R., Osher F. The Dually Diganosed, in Integrated Mental Health Services. 1996
- Fisher C. M. “Catatonia” due to disulfiram toxicity. Arch Neurol 1989; 46(797–804)
- Frezza M., Di Padova C. High blood alcohol levels in woemen. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. New England Journal of Medicine 1990; 322(2)95–99, [PUBMED], [INFOTRIEVE]
- Fuller R., Gordis E. Naltrexone treatment for alcohol dependence. The New England Journal of Medicine 2001; 345(24)1770–1771, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Fuller R., Roth H. Compliance with disulfiram treatment of alcoholism. Journal of Chronic Diseases 1983; 36: 161–170, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Fuller R. K., Branchey L. Disulfiram treatment of alcoholism: A veterans administration cooperative study. Journal of American Medical Association 1986; 256: 1449–1455, [CROSSREF]
- Garbutt J., West S. Pharmacological treatment of alcohol dependence, a review of the evidence. Journal of American Medical Association 1999; 281: 1318–1325, [CROSSREF]
- Gardell L., Whalen C. Calproate reduces intake of alcoholic beverage among rats. Behavioral Pharmacology 1998; 9(8)683–689
- Gastpar M. T., Bonnet U. Lack of efficacy of naltrexone in the prevention of alcohol relapse: resultes from a German multicenter study. Journal of Clinical Psychopharmacology 2002; 22(6)592–598, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Genazzani A. R., Nappi G. Central deficiency of beta-endorphin in alcohol addicts. Journal of Clinical Endocrinology & Metabolism 1982; 55(3)583–586, [INFOTRIEVE]
- Gianoulakis C., de Waele J. P. Implication of the endogenous opioid system in excessive ethanol consumption. Alcohol 1996; 13(1)19–23, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Grant B. Prevelance and correlates of alcohol use and DSM-IV alcohol dependence in the United States: results of the national longitudinal alcohol epidemiologic survey. Journal of Studies on Alcohol 1997; 58(5)464–473, [PUBMED], [INFOTRIEVE]
- Grant K. A., Colombo G. Characterization of the ethanol-like discriminative stimulus effects of 5-HT receptor agonists as a function of ethanol training dose. Psychopharmacology 1997; 133(2)133–141, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Group T. C. S.R. Testing combined pharmacotherapies and behavioral interventions for alcohol dependence (The COMBINE study): a pilot feasibility study. Alcoholism Clinical & Experimental Research 2003; 27(7)1123–1131, [INFOTRIEVE], [CROSSREF]
- Harwood H. 10th Special Repot to the US Congress on Alcohol and Health. US Department of Health and Human Services. 1998
- Hodge C., Chappelle A. Dopamine receptors in the medial prefrontal cortex influence ethanol and sucrose-reinforced responding. Alcoholism Clinical & Experimental Research 1996; 20: 1631–1638, [INFOTRIEVE]
- Hoffman P., Rabe C. N-methyl-D-aspartate receptors and ethanol: inhibition of calcium flux and cyclic GMP production. Journal of Neurochemistry 1989; 52: 1937–1940, [PUBMED], [INFOTRIEVE]
- Hoffman P. L. Glutamate receptors in alcohol withdrawal-induced neurotoxicity. Metabolic Brain Disease 1995; 10(1)73–79, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hutchison K. E., Swift R. Olanzapine reduces urge to drink after drinking cues and a priming dose of alcohol. Psychopharmacologia 2001; 155(1)27–34, [CROSSREF]
- Joca S., Skalisz L. The antidepressive-like effect of oxcarbazepine: possible role of dopaminergic neurotransmission. European Neuropsychopharmacology 2000; 10(4)223–228, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Johnson B., Ait-Daoud N. Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet 2003; 361: 1677–1685, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Johnson B., Roache J. Ondansetron for reduction of drinking among biologically predisposed alcoholic patients—a randomized controlled trial. Journal of American Medical Association 2000; 284(8)963–971, [CROSSREF]
- Johnson B. A., Jasinski D. R. Ritanserin in the treatment of alcohol dependence–a multi-center clinical trial. Ritanserin study group. Psychopharmacology (Berl) 1996; 128(2)206–215, [CROSSREF]
- Karam-Hage M., Bower K. Gabapentin treatment for insomnia associated with alcohol dependence. American Journal of Psychiatry 2000; 157(1)151, [PUBMED], [INFOTRIEVE]
- Keane T. M., Foy D. W. Spouse contracting to increase antabuse compliance in alcoholic veterans. Journal of Clinical Psychology 1984; 40: 340–344, [PUBMED], [INFOTRIEVE]
- Kessler R., McGonagle K. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the national comorbidity survey. Archives of General Psychiatry 1994; 51: 8–19, [PUBMED], [INFOTRIEVE]
- Kessler R. C., Nelson C. B. The epidemiology of co-occuring addictive and mental disorders: implications of prevention and service utilization. American Journal of Orthopsychiatry 1996; 66(1)17–31, [PUBMED], [INFOTRIEVE]
- Kiefer F., Jahn H. Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study. Archives of General Psychiatry 2003; 60(1)92–99, [PUBMED], [INFOTRIEVE]
- Klingemann H. K., Sobell L. C. Introduction: natural recovery research across substance use. Substance Use & Misuse 2001; 36(11)1409–1416, [INFOTRIEVE]
- Knapp C. Drinking: A Love Story. Dell Publishing, New York 1996
- Koob G. F., Bloom F. E. Cellular and molecular mechanisms of drug dependence. Science 1988; 242: 715–723, [PUBMED], [INFOTRIEVE]
- Kranzler H., Burleson J. Fluoxetine treatment seems to reduce the beneficial effects of cognitive-behavioral therapy in type B alcoholics. Alcoholism, Clinical & Experimental Research 1996; 20: 1534–1541, [INFOTRIEVE]
- Kranzler H., Modesto-Lowe V. Naltrexone vs. nefazodone for treatment of alcohol dependence. A placebo-controlled trial. Neuropsychopharmacology 2000; 22(5)493–503, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kranzler H., Van Kirk J. Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis. Alcoholism, Clinical and Experimental Research 2001; 25: 1335–1341, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kranzler H. R., Burleson J. A. Buspirone treatment of anxious alcoholics. A placebo-controlled trial. Archives of General Psychiatry 1994; 51(9)720–731, [PUBMED], [INFOTRIEVE]
- Kranzler H. R., Burleson J. A. Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics. American Journal of Psychiatry 1995; 152(3)391–397, [PUBMED], [INFOTRIEVE]
- Kranzler H. R., Jaffe J. H. Pharmacologic Therapies for Alcoholism. Principles of Addiction Medicine. 2nd ed. 1998
- Krystal J., Cramer J. Naltrexone in the treatment of alcohol dependence. The New England Journal of Medicine 2001; 345(24)1734–1739, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Krystal J. H., Karper L. P. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Archives of General Psychiatry 1994; 51(3)199–214, [PUBMED], [INFOTRIEVE]
- Krystal J. H., Petrakis I. L. Dose-related ethanol-like effects of the NMDA antagonist, ketamine, in recently detoxified alcoholics. Archives of General Psychiatry 1998; 55: 354–360, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Larson E. W., Olincy A. Disulfiram treatment of patients with both alcohol dependence and other psychiatric disorders: a review. Alcoholism, Clinical & Experimental Research 1992; 16(1)125–130, [INFOTRIEVE]
- Li T., Spanagel R. Alcohol reinforcement and voluntary ethanol consumption. Alcoholism, Clinical and Experimental Research 2001; 25(5)117S–126S, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Littleton J. Acamprosate in alcohol dependence: how does it work?. Addiction 1995; 90(9)1179–1188, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Loi C., Day J. Dose-dependent inhibition of theophylline metabolism by disulfiram in recovering alcoholics. Clinical Pharmacology & Therapeutics 1989; 45: 476–486, [INFOTRIEVE]
- Maany I., Hayashida M. Possible toxic interaction between disulfiram and amitriptyline. Archives of General Psychiatry 1982; 142: 1373–1374
- MacLeod S., Sellers E. Interaction of disulfiram with benzodiazepines. Clinical Pharmacology & Therapeutics 1978; 24: 583–589, [INFOTRIEVE]
- Malcolm R., Myrick H. The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial. Journal of General Internal Medicine 2002; 17(5)349–355, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Malec E., Malec T. Buspirone in the treatment of alcohol dependence: a placebo-controlled trial. Alcoholism, Clinical & Experimental Research 1996; 20(2)307–312, [INFOTRIEVE]
- Mann K., Batra A. Do women develop alcoholic brain damage more readily than men?. Alcoholism, Clinical and Experimental Research 1992; 16(6)1052–1056, [PUBMED], [INFOTRIEVE]
- Mark T., Kranzler H. R. Physicians' opinions about medications to treat alcoholism. Addiction 2003; 98: 617–626, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Marra D., Warot D. Amisulpride does not prevent relapse in primary alcohol dependence: results of a pilot randomized, placebo-controlled trial. Alcoholism, Clinical and Experimental Research 2002; 26(10)1545–1552, [PUBMED], [INFOTRIEVE]
- Mason B. Acamprosate: new preclinical and clinical findings. 2000 Scientific Meeting of the Research Society on Alcoholism, Denver, CO 2000
- Mason B. Treatment of alcohol-dependent outpatients wiht acamprosate: a clinical review. Journal of Clinical Psychiatry 2001; 62(20)42–48, [PUBMED], [INFOTRIEVE]
- Mason B. J., Ritvo E. C. A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence. Alcoholism, Clinical & Experimental Research 1994; 18(5)1162–1167, [INFOTRIEVE]
- Mason N. Disulfiram-induced hepatitis: case report and review of the literature. DICP 1989; 23: 872–875, [PUBMED], [INFOTRIEVE]
- Maxwell S., Shinderman M. S. Use of naltrexone in the treatment of alcohol use disorders in patients with concomitant major mental illness. Journal of Addictive Diseases 2000; 19(3)61–69, [PUBMED], [INFOTRIEVE], [CROSSREF]
- McCance-Katz E. F., Kosten T. R., Jatlow P. Disulfiram effects on acute cocaine administration. Drugs & Alcohol Dependence 1998; 52(1)27–39, [INFOTRIEVE], [CROSSREF]
- Mezey E., Kolman C. Alcohol and dietary intake in the development of chronic pancreatitis and liver disease in alcoholism. American Journal of Clinical Nutrition 1988; 48(1)148–151, [PUBMED], [INFOTRIEVE]
- Morris P. L., Hopwood M. Naltrexone for alcohol dependence: a randomized controlled trial, [comment]. Addiction. 2001; 96(11)1565–1573, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Mueller T. I., Stout R. L. A double-blind, placebo-controlled pilot study of carbamazepine for the treatment of alcohol dependence. Alcoholism, Clinical and Experimental Research 1997; 21(1)86–92, [PUBMED], [INFOTRIEVE]
- Mueser K., Noordsy D. Disulfiram treatment for alcoholism in severe mental illness. The American Journal on Addictions 2003; 12: 242–252, [PUBMED], [INFOTRIEVE]
- Myrick H., Brady K. T. New developments in the pharmacotherapy of alcohol dependence. American Journal of Addictions 2001; 10: 16–23, Suppl:
- Namkoong K., Bo L. Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study. Alcohol & Alcoholism 2003; 38(2)135–141, [INFOTRIEVE], [CROSSREF]
- Nasr S. Oxcarbazepine for mood disorders. American Journal of Psychiatry 2002; 159(10)1793, [PUBMED], [INFOTRIEVE], [CROSSREF]
- O'Farrell T. J., Bayog R. D. Antabuse contracts for married alcoholics and their spouses: a method to maintain antabuse ingestion and decrease conflict about drinking. Journal of Substance Abuse Treatment 1986; 3: 1–8, [PUBMED], [INFOTRIEVE], [CROSSREF]
- O'Malley S. S. Strategies to maximize the efficacy of naltrexone for alcohol dependence. NIDA Research Monograph 1995; 150: 53–64, [PUBMED], [INFOTRIEVE]
- O'Malley S. S., Jaffe A. J. Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Arch Gen Psychiatry 1992; 49(11)881–887, [PUBMED], [INFOTRIEVE]
- O'Reilly R. Dynamic interaction between disulfiram and separated enantiomorphs of racemic warfarin. Clinical Pharmacology & Therapeutics 1981; 29: 332–336, [INFOTRIEVE]
- Paille F. M., Guelfi J. D. Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol. Alcohol & Alcoholism 1995; 30(2)239–247, [INFOTRIEVE]
- Pelc I., Ansoms C. The European NEAT program: an integrated approach using acamprosate and psychosocial support for the prevention of relapse in alcohol-dependent patients with a statistical modeling of therapy success prediction. Alcoholism, Clinical and Experimental Research 2002; 26(10)1529–1538, [PUBMED], [INFOTRIEVE]
- Pelc I., Verbanck P. Efficacy and safety of acamprosate in the treatment of detoxified alcohol-dependent patients. A 90-day placebo-controlled dose-finding study. British Journal of Psychiatry 1997; 171: 73–77, [PUBMED], [INFOTRIEVE]
- Petrakis I., Trevisan L. CSF monoamine metabolite and beta-endorphin levels in recently detoxified alcoholics and healthy controls: prediction of alcohol cue-induced craving. Alcoholism, Clinical and Experimental Research 1999; 23(8)1336–1341, [PUBMED], [INFOTRIEVE]
- Petrakis I. L., Carroll K. M. Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts. Addiction 2000; 95(2)219–228, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Petrakis I. L., Leslie D. Use of naltrexone in the treatment of alcoholism nationally in the department of veterans affairs. Alcoholism, Clinical and Experimental Research 2003; 27(11)1780–1784, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Petrakis I. L., O'Malley S. Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia. Psychopharmacology 2004; 172: 291–297, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Petrakis I. L., Trevisan L. Effect of tryptophan depletion on alcohol cue-induced craving in abstinent alcoholic patients. Alcoholism, Clinical and Experimental Research 2001; 25(8)1151–1155, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Pettinati H., Oslin D. Role of serotonin and serotonin-selective pharmacotherapy in alcohol dependence. The International Journal of Neuropsychiatric Medicine 2000; 5(2)33–46
- Pettinati H. M. The use of selective serotonin reuptake inhibitors in treating alcoholic subtypes. Journal of Clinical Psychiatry 2001; 62(20)26–31, Suppl[PUBMED], [INFOTRIEVE]
- Pettinati H. M., Volpicelli J. R. Sertraline treatment for alcohol dependence: interactive effects of medication and alcoholic subtype. Alcoholism, Clinical & Experimental Research 2000; 24(7)1041–1049, [INFOTRIEVE], [CROSSREF]
- Poldrugo F. Acamprosate treatment in a long-term community based alcohol rehabilitation programme. Addiction 1997; 92(11)1537–1546, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Regier D. A., Farmer M. E. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) study [see comments]. Journal of American Medical Association 1990; 264(19)2511–2518, [CROSSREF]
- Roussaux J. P., Hers D. [Does acamprosate deminish the appetite for alcohol in weaned alcoholics?]. Journal de Pharmacie de Belgique 1996; 51(2)65–68, [PUBMED], [INFOTRIEVE]
- Roy A., Linnoila M. CSF studies on alcoholism and related behaviours. Progress in Neuro-Psychopharmacology & Biological Psychiatry 1989; 13(3–4)505–511, [INFOTRIEVE]
- Salloum I., Cornelius J. Naltrexone utility in depressed alcoholics. Psychopharmacology 1998; 34(1)111–115
- SAMSHSA. National survey on drug use and health. Substance Abuse and Mental Health Services Administration, Rockville, MD 2002
- Sass H., Soyka M. Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence [published erratum appears in Arch Gen Psychiatry 1996 Dec;53(12):1097]. Arch Gen Psychiatry 1996; 53(8)673–680, [PUBMED], [INFOTRIEVE]
- Schutz C., Soyka M. Dextromethorphan challenge in alcohol-dependent patients and controls (letter, comment). Archives of General Psychiatry 2000; 57: 291–292, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Sellers E. M., Toneatto T. Clinical efficacy of the 5-HT3 antagonist ondansetron in alcohol abuse and dependence. Alcoholism, Clinical and Experimental Research 1994; 18(4)879–885, [PUBMED], [INFOTRIEVE]
- Shaw G., Majumdar S. Tiapride in the long-term management of alcoholics of anxious or depressive temperament. British Journal of Psychiatry 1987; 150: 164–168, [PUBMED], [INFOTRIEVE]
- Thomas C., Wallack S. Research to practice: Adoption of naltrexone in alcoholism treatment. Journal of Substance Abuse Treatment 2003; 24: 1–11, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Tornabene V. Narcotic withdrawal syndrome caused by naltrexone. Annals of Internal Medicine 1974; 81(6)785–787, [PUBMED], [INFOTRIEVE]
- Tsai G., Gastfriend D. R. The glutamatergic basis of human alcoholism [see comments]. American Journal of Psychiatry 1995; 152(3)332–340, [PUBMED], [INFOTRIEVE]
- Upton R. Pharmacokinetic interactions between theophylline and other medication (part 1). Clinical Pharmacokinetics 1991; 20: 66–80, [PUBMED], [INFOTRIEVE]
- Urbano-Marquez A., Estruch R. The greater risk of alcoholic cardiomyopathy and myopathy in women compared with men. JAMA 1995; 274(2)149–154, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Volkow N. D., Fowler J. Role of dopamine, the frontal cortex, and memory circuits in drug addiction: insight from imaging studies. Neurobiology of Learning & Memory 2002; 78(3)610–624, [INFOTRIEVE], [CROSSREF]
- Volpicelli J. R., Alterman A. Naltrexone in the treatment of alcohol dependence. Archives of General Psychiatry. 1992; 49(11)876–880, [PUBMED], [INFOTRIEVE]
- Volpicelli J. R., Alterman A. I. Naltrexone in the treatment of alcohol dependence [see comments]. Archives of General Psychiatry 1992; 49(11)876–880, [PUBMED], [INFOTRIEVE]
- Volpicelli J. R., Rhines K. C. Naltrexone and alcohol dependence. Role of subject compliance [see comments]. Archives of General Psychiatry 1997; 54(8)737–742, [PUBMED], [INFOTRIEVE]
- Weinstein A., Feldtkeller B. A pilot study on the effects of treatment with acomprosate on craving for alcohol in alcohol dependent patients. Addiction Biology 2003; 8(2)229–232, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Weiss F., Lorang M. Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: genetic and motivational determinants. Journal of Pharmacology and Experimental Theraputics 1993; 267: 250–258
- Whitworth A. B., Fischer F. Comparison of acamprosate and placebo in long-term treatment of alcohol dependence [see comments]. Lancet 1996; 347(9013)1438–1442, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Wilsnack S., Wilsnack R. Epidemiology of Women's Drinking. Journal of Substance Abuse 1991; 3(2)133–157, [PUBMED], [INFOTRIEVE]
- Ziedonis D., Brady K. Dual diagnosis in primary care. Detecting and treating both the addiction and mental illness. Medical Clinics of North America 1997; 81(4)1017–1036, [PUBMED], [INFOTRIEVE], [CROSSREF]